75th Annual Meeting of the American Academy of Neurology

Long-term safety and efficacy of add-on cannabidiol (CBD) for seizures associated with tuberous sclerosis complex (TSC): 3-year results from GWPCARE6 open-label extension (OLE)

Author(s): Elizabeth Thiele MD, PhD, Massachusetts General Hospital

Neuroscience

View Poster

Characteristics and Disease Burden of Patients With Idiopathic Hypersomnia With and Without Long Sleep Time: The Real World Idiopathic Hypersomnia Outcomes Study (ARISE)

Author(s): Logan Schneider, MD Joanne Stevens, BA Aatif M. Husain, MD Diane Ito, MA Douglas S. Fuller, MS Wayne Macfadden, MD

Neuroscience

View Poster

Increased Risk of Hypertension Onset Among Patients With Narcolepsy Newly Treated With High-Sodium Oxybate

Author(s): Rami H. Ben-Joseph, PhD Virend K. Somers, MD, PhD Jed Black, MD Ralph B. D’Agostino, Jr., PhD Ragy Saad, MSc Mat Davis, PhD Wayne Macfadden, MD Katherine E. Mues, PhD Clark Jackson, MPH Weiyi Ni, PhD Julia Pitino, BS Helen Latimer, MPH Elizabeth C. Dabrowski, MS William B. White, MD

Neuroscience

View Poster

Effects of Low-Sodium Oxybate on 24-Hour Total Sleep Time: Data From a Phase 3 Clinical Study in Adults With Idiopathic Hypersomnia

Author(s): Anne Marie Morse, DO Abby Chen, MS Teresa L. Steininger, PhD Wayne Macfadden, MD

Neuroscience

View Poster

Nonseizure outcomes with cannabidiol (CBD) in pediatric versus adult patients with Lennox-Gastaut syndrome (LGS) and Dravet syndrome (DS): subgroup analysis of BECOME, a caregiver survey

Author(s): Tracy Dixon-Salazar Ph.D., LGS Foundation

Neuroscience

View Poster

Effectiveness and Optimization of Low-Sodium Oxybate in Participants With Narcolepsy Switching From High-Sodium Oxybate: Interim Data From the Substitution of Equal Grams of Uninterrupted Xyrem to Xywav (SEGUE) Study

Author(s): Eileen B. Leary, PhD, RPSGT M. Todd Kirby, PhD Roman Skowronski, MD, PhD Kevin Xu, MA Craig Pfister, BSc Wayne Macfadden, MD